Aarhus University Seal / Aarhus Universitets segl

English

Du er her: AU Om AU  Newsroom Nyheder Vis

Seminar: PD-1 in cancer, implications for immunotherapy

PD-1 is a central placed co-stimulatory factor that plays an important role in keeping our immunological tolerance.

11.06.2015 | Mads Henning Jensen

Dato ons 23 sep
Tid 12:00 — 15:00
Sted Merete Barker Auditorium
Email Facebook LinkedIn

Recently anti-PD-1 and anti-PD-L1 antibodies have shown to be extremely potent treatments for various cancers.

MSD Denmark and Merck Research labs, Palo Alto, will host a seminar on the PD-1 axis.

The talks will be given by Elaine Pinheiro, from Merck Research labs, Boston and Jennifer H. Yearley, both from Merck Research labs, Palo Alto. They have both played a central role in the development of anti-PD-1 treatment for Merck/MSD.

Sandwiches will be provided by MSD Denmark during the seminar.

Detailed program for the seminar.

Seminar, Sundhed og sygdom, Videnskabelig medarbejder, Institut for Biomedicin, Health, Teknisk/administrativ medarbejder, Offentligheden/Pressen

Nyhedsarkiv

Revideret 20.05.2022 - 
Mads Henning Jensen